A carregar...

Cost-effectiveness of buffered soluble alendronate 70 mg effervescent tablet for the treatment of postmenopausal women with osteoporosis in Italy

SUMMARY: The use of buffered soluble alendronate 70 mg effervescent tablet, a convenient dosing regimen for bisphosphonate therapy, seems a cost-effective strategy compared with relevant alternative treatments for postmenopausal women with osteoporosis aged 60 years and over in Italy. INTRODUCTION:...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Osteoporos Int
Main Authors: Hiligsmann, M., Maggi, S., Veronese, N., Sartori, L., Reginster, J.-Y.
Formato: Artigo
Idioma:Inglês
Publicado em: Springer London 2021
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7929941/
https://ncbi.nlm.nih.gov/pubmed/33443610
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00198-020-05802-5
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!